Hydroxychloroquine trials halted amid safety fears, children up to 56% less likely than adults to be infected by coronavirus and more.
COVID-19: a round up of this week’s top science stories World Economic Forum
Hydroxychloroquine trials halted amid safety fears, children up to 56% less likely than adults to be infected by coronavirus and more.
COVID-19: a round up of this week’s top science stories World Economic Forum